Skip to main content

View full-text article in PMC

. 2018 Jun 1;32(6):215–222. doi: 10.1089/apc.2018.0052

Table 3.

Factors Associated with Metabolic Syndrome Among HIV-Infected Patients

	Univariate analysis			Multivariate analysis
	OR	95% CI	p	Adjusted OR	95% CI	p
Male sex	0.30	0.14–0.68	0.004	0.22	0.09–0.56	0.001
Age groups,^a years
≥55	2.54	1.08–5.95	0.03	3.35	1.20–9.33	0.02
ART use	0.88	0.48–1.64	0.70	—
HIV duration	1.01	0.95–1.07	0.84	—
BMI ≥25 kg/m^b	3.42	1.78–6.5	<0.001	2.83	1.38–5.82	0.005
LDL	1.02	1.01–1.05	0.01	—
HIV viral load >100,000 copies/mL	2.88	0.66–12.49	0.16	—
HIV stage 4^c	0.96	0.70–1.31	0.79	—
CD4 nadir^d <200 cells/mm³	1.26	0.64–2.46	0.51	—

^{^a}

Versus age groups 18–54 years.

^{^b}

Reference BMI <25 kg/m².

^{^c}

Reference HIV stages 1–3.

^{^d}

Reference Nadir CD4 ≥ 200 cells/mm³.

CI, confidence interval; ART, antiretroviral therapy; LDL, low-density lipoprotein; BMI, body mass index; OR, odds ratio.